Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Set for Strong Expansion, Reaching $12.97 Billion With 16.2% CAGR by 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the messenger ribonucleic acid (mrna) manufacturing service market from 2026–2035 with trusted insights from The Business Research Company
What is the expected shift in the Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market’s size between 2026 and 2030?
The messenger ribonucleic acid (mrna) manufacturing service market size has experienced rapid expansion in recent years. This market is projected to increase from $6.14 billion in 2025 to $7.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. Historically, this growth can be attributed to the rise of mrna therapeutics research, urgent demands for vaccine manufacturing, limited in-house mrna capacity, the growth of CDMO partnerships, and the expansion of biotech pipelines.
The messenger ribonucleic acid (mrna) manufacturing service market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $12.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.2%. This anticipated growth during the forecast period is fueled by several factors, including a rise in mrna therapy trials, an increase in contract manufacturing requirements, the advancement of personalized medicine, increased outsourcing activities by biotechnology companies, and the scaling up of commercial mrna products. Key trends emerging in this period encompass integrated mrna process development services, large-scale in vitro transcription production, comprehensive end-to-end LNP encapsulation services, swift technology transfer initiatives, and the manufacturing of GMP-grade mrna batches.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33216&type=smp
Which Drivers Are Shaping Strategic Decisions In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Increased clinical trial activity is projected to drive the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market in the future. Clinical trial activity encompasses all procedures for conducting and overseeing human clinical studies to assess medical interventions. This rise in activity is fueled by the growing adoption of digital and decentralized trial models, which facilitate quicker patient enrollment, remote oversight, and more streamlined data gathering across wider demographics. Messenger ribonucleic acid (mRNA) manufacturing services support clinical trials by providing swift and adaptable production of mRNA-based therapies, guaranteeing prompt availability for various trial stages and speeding up drug development. As an illustration, the Association of the British Pharmaceutical Industry (ABPI) reported that the number of industry clinical trials launched in the UK climbed to 426 in 2023, up from 411 in 2022. Consequently, the heightened clinical trial activity is a key factor boosting the messenger ribonucleic acid (mRNA) manufacturing service market’s growth.
What Segment Classifications Make Up The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
The messenger ribonucleic acid (mrna) manufacturing service market covered in this report is segmented –
1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types
2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale
3) By Application: Vaccines; Therapeutics; Research; Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support
2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing
3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production
4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage
5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions
What Trends Are Expected To Impact The Competitive Landscape Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?
Entities in the messenger ribonucleic acid (mRNA) manufacturing service market are actively developing innovative solutions, including in vitro transcription (IVT), to accelerate the production of premium, clinical-grade mRNA for vaccines and customized therapies. In vitro transcription (IVT) is a laboratory method that synthesizes messenger RNA (mRNA) from a DNA template using RNA polymerase enzymes, enabling the creation of mRNA outside living cells for various research, therapeutic, or vaccine applications. For instance, in May 2025, GenScript Biotech Corporation, a China-based biotechnology company, launched a GMP-like mRNA manufacturing service designed to support preclinical studies and IND-enabling research. This solution provides high-purity, scalable in vitro transcription (IVT) processes with rigorous control over critical quality attributes such as capping efficiency, poly(A) tail length, and impurity profiles. It aids a rapid transition from preclinical to clinical stages by ensuring consistent batch-to-batch production, flexible customization for different mRNA constructs, and reduced development timelines. Additionally, the GMP-like framework enhances regulatory readiness through improved traceability, standardized workflows, and comprehensive quality documentation, helping developers mitigate risks in later-stage manufacturing and accelerate clinical progress.
Which Leading Companies Dominate The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Share?
Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.
Access The Complete Report For Deeper Market Insights:
How Does The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Perform Across Major Global Regions?
North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=33216&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Ribonucleic Acid Rna Sequencing Market Report 2026
Nucleic Acid Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/nucleic-acid-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
